Please turn on your JavaScript for this page to function normally.
Novartis
Cohesity announces valuation of $3.7B following a growth in annual recurring revenues
Cohesity announced a new company valuation of $3.7 billion, which is $1.2 billion higher than its valuation less than 12 months ago. This dramatic growth in valuation …
Novartis leverages AWS’ portfolio of cloud services to build an enterprise-wide data and analytics platform
Amazon Web Services (AWS), an Amazon.com company, announced a multi-year strategic collaboration with Novartis to reimagine this leading pharmaceutical company’s core …
Featured news
Sponsored
Don't miss
- Applying DevSecOps principles to machine learning workloads
- Overcoming GenAI challenges in healthcare cybersecurity
- 25 cybersecurity AI stats you should know
- Hackers backdoored Cisco ASA devices via two zero-days (CVE-2024-20353, CVE-2024-20359)
- PoC for critical Progress Flowmon vulnerability released (CVE-2024-2389)